Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SinotherapeuticsSHSE:688247 +3.79%72 Days Inventory is 108.80 as of Mar. 2026, which is 26% below its 10-year median of 147.61. GuruFocus rates SHSE:688247 with a GF Score™ of 72/100 and a GF Value™ of ¥11.40 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, Sinotherapeutics ranks better than 70.72% on this metric.
The historical rank and industry rank for Sinotherapeutics's Days Inventory or its related term are showing as below:
SHSE:688247'
s Days Inventory Range Over the Past 10 Years
Min: 50.45 Med: 147.61 Max: 217.5
Current: 119.68
During the past 8 years, Sinotherapeutics's highest Days Inventory was 217.50. The lowest was 50.45. And the median was 147.61.
SHSE:688247's Days Inventory is ranked better than 70.72% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.58
vs SHSE:688247: 119.68
Sinotherapeutics's Days Inventory
declined
from Mar. 2025 (142.81) to Mar. 2026 (108.80).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sinotherapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.84.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sinotherapeutics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.73.
Sinotherapeutics (SHSE:688247) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sinotherapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sinotherapeutics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sinotherapeutics Days Inventory Related Terms
Sinotherapeutics Days Inventory Historical Data
* Premium members only.
The historical data trend for Sinotherapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sinotherapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinotherapeutics Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sinotherapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sinotherapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinotherapeutics (SHSE:688247) has a Days Inventory of 108.80 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sinotherapeutics and its competitors. This is 26% below median its historical median of 147.61. Over the past decade, Sinotherapeutics' Days Inventory has ranged from 50.45 to 217.50. According to the industry distribution chart, Sinotherapeutics ranks #270 out of 922 companies in the Drug Manufacturers industry, placing it in the top 29.3%.
Is Sinotherapeutics' Days Inventory too high?
Sinotherapeutics' current Days Inventory of 108.80 is 26% below median its 10-year median of 147.61. Over the past 10 years, this metric has ranged from a low of 50.45 to a high of 217.50. The Drug Manufacturers industry median Days Inventory is 164.58. Sinotherapeutics' value of 108.80 is 33.9% below this industry median. Based on the distribution chart, Sinotherapeutics ranks #270 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sinotherapeutics has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinotherapeutics' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sinotherapeutics ranks #270 out of 922 companies for Days Inventory. This puts Sinotherapeutics in the upper half of its industry. The industry median Days Inventory is 164.58. Sinotherapeutics' value of 108.80 is 33.9% below this benchmark. Historically, Sinotherapeutics' own Days Inventory has ranged from 50.45 to 217.50 over the past decade. While the company's 10-year median is 147.61 vs. the industry median of 164.58, Sinotherapeutics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.58, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sinotherapeutics's current Days Inventory of 108.80 is 33.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sinotherapeutics and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinotherapeutics's current Days Inventory is 108.80, which is 26% below median its own 10-year median of 147.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinotherapeutics stock overvalued right now?
Based on GuruFocus' analysis, Sinotherapeutics (SHSE:688247) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥11.40, compared to a current price of ¥8.48 — trading 25.6% below its estimated fair value. The current Days Inventory is 108.80, which is 26% below median its 10-year median of 147.61 and 33.9% below the Drug Manufacturers industry median of 164.58. Sinotherapeutics' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sinotherapeutics (SHSE:688247), the current Days Inventory is 108.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinotherapeutics (SHSE:688247) Overvalued in 2026?
Based on GuruFocus' analysis, Sinotherapeutics stock appears to be undervalued.
The current stock price of ¥8.48 is trading 25.6% below its estimated GF Value™ of ¥11.40.
GuruFocus considers Sinotherapeutics to be Modestly Undervalued.
Key valuation signals for SHSE:688247:
Days Inventory: 108.80 (26% below median its 10-year median of 147.61)
GF Value™: ¥11.40 vs. price of ¥8.48 (25.6% below fair value)
Industry Position: 33.9% below the Drug Manufacturers median (#270 of 922)
No single metric tells the full story. See the SHSE:688247 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688247 has been successfully added to your 
